Pre-earnings options volume in Iovance Biotherapeutics is 1.8x normal with calls leading puts 9:1. Implied volatility suggests the market is anticipating a move near 15.7%, or $1.24, after results are released. Median move over the past eight quarters is 4.1%.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- IOVA Earnings this Week: How Will it Perform?
- Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
- Iovance Biotherapeutics downgraded to Neutral from Overweight at Piper Sandler
- Iovance Biotherapeutics put volume heavy and directionally bearish
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)